• SENSEX 77,761.12
    -205.23 (--0.26%)
  • BANKNIFTY 57,885.85
    439.60 (+0.77%)
  • UltraTech Cem.
    11,575.00 10,329.00(%)
  • Thyrocare Tech.
    609.60 342.55(%)
  • Bharti Airtel
    1,970.05 2,174.70(%)
  • Godrej Consumer
    918.35 1,308.40(%)
  • Cupid
    295.00 290.00(%)
  • Netweb Technol.
    5,114.35 5,241.65(%)
  • Lenskart Solut.
    627.35 595.70(%)
  • Astral
    1,599.00 1,767.95(%)
  • Fortis Health.
    901.50 1,105.00(%)
  • Hindustan Copper
    570.00 759.20(%)
  • Jio Financial
    263.35 333.65(%)
  • NTPC
    341.80 414.40(%)
  • Cummins India
    5,429.90 6,142.80(%)
  • Tata Motors
    485.00 508.95(%)
  • Cyient
    878.00 1,282.40(%)
  • M & M
    3,375.05 2,896.30(%)
  • Bluestone Jewel
    885.00 400.40(%)
  • Hind.Aeronautics
    5,048.00 5,054.40(%)
  • Vodafone Idea
    13.87 15.35(%)
  • Hyundai Motor I
    2,273.65 2,889.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Abbott India Ltd Pharmaceuticals - Multinational

  • MNC Asc-Abbott
  • BSE Code : 90.0
  • ISIN : INE358A01014
28,140.00 120 (0.43%)
  • As on 13 Aug 2026 (EOD)

  • Today’s Low

    27,755.00

  • Today’s High

    28,250.00

  • Open

    28,020.00

  • Perv Close

    28,020.00

  • 52W Low

    25,150.00

  • 52W High

    34,060.00

Key Indicators

  • P/E(TTM)

    38.67

  • Mar.Cap (₹Cr.)

    59,797.50

  • Div & Yield %

    2.33

  • Book Value(₹)

    2,246.68

  • Debt-Equity Ratio

    0.43

  • AGM Date

    12-Aug-2026

  • EPS

    727.90

  • P/E Ratio

    38.67

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    59,797.50

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    21.25

  • BV (₹)

    2,246.70

  • Sales( ₹ in Cr.)

    6,960.49

  • NP (in Cr.)

    1,546.80

  • NP Var(%)

    9.0

  • Div%

    6560.0

  • CPS (₹)

    763.60

  • EPS (₹)

    727.90

  • Traded Value (₹ in Lakhs)

    59,812.16

  • 52 Week High

    34,060.00

  • 52 Week Low

    25,150.00

  • Price BSE

    28147.0

  • Price NSE

    28,140.00

  • Market Capital( in Cr.)

    59,812.16

  • P/C Ratio

    36.90

  • P/E Ratio

    38.70

  • Price Vs.BV

    727.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 6,960.49 6,445.79 5,875.26 5,379.08 4,919.27 4,310.02
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 6,960.49 6,445.79 5,875.26 5,379.08 4,919.27 4,310.02
Other Income 288.14 275.58 248.27 154.15 77.21 80.90
Stock Adjustments 85.29 180.68 -7.73 -66.09 22.28 104.00
Total Income 7,333.92 6,902.05 6,115.80 5,467.14 5,018.76 4,494.92
EXPENDITURE :            
Raw Materials 3,778.11 3,677.46 3,212.88 2,908.97 2,679.49 2,494.92
Power and Fuel Cost 14.61 15.43 16.63 17.15 14.98 12.74
Employee Cost 668.82 587.54 576.58 563.59 579.46 492.65
Other Manufacturing Expenses 145.04 134.09 126.47 59.21 59.82 49.66
Selling and Administration Expenses 480.63 448.84 429.89 467.74 439.93 366.98
Miscellaneous Expenses 66.49 68.51 51.98 90.70 80.15 75.61
Employee Benefit Expenses 668.82 587.54 576.58 563.59 579.46 492.65
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5,153.70 4,931.87 4,414.43 4,107.36 3,853.83 3,492.56
Operating Profit 2,180.22 1,970.18 1,701.37 1,359.78 1,164.93 1,002.36
Interest 24.99 11.43 12.45 15.99 19.10 18.28
Gross Profit 2,155.23 1,958.75 1,688.92 1,343.79 1,145.83 984.08
Depreciation 75.96 71.80 71.17 69.97 66.10 58.13
Profit Before Tax 2,079.27 1,886.95 1,617.75 1,273.82 1,079.73 925.95
Current Tax 537.97 469.79 415.46 325.60 281.16 239.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -10.72 2.72 1.07 -1.19 -0.13 -3.79
Reported Net Profit 1,552.02 1,414.44 1,201.22 949.41 798.70 690.69
Extraordinary Items 5.22 -0.48 0.12 -0.19 0.00 -0.18
Adjusted Net Profit 1,546.80 1,414.92 1,201.10 949.60 798.70 690.87
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 3,220.78 2,819.01 2,428.51 2,158.40 2,023.93 1,933.54
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1,164.54 1,012.67 810.72 679.30 664.23 600.30
P & L Balance carried down 3,608.26 3,220.78 2,819.01 2,428.51 2,158.40 2,023.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 6,560.00 4,750.00 4,100.00 3,250.00 2,750.00 2,750.00
Dividend Per Share(Rs) 656.00 475.00 410.00 325.00 275.00 275.00
Earnings Per Share-Unit Curr 730.36 665.62 565.28 446.78 375.86 325.03
Earnings Per Share(Adj)-Unit Curr 730.36 665.62 565.28 446.78 375.86 325.03
Book Value 2,246.68 1,992.07 1,740.65 1,500.49 1,326.96 1,224.55
Book Value(Adj)-Unit Curr 2,246.68 1,992.07 1,740.65 1,500.49 1,326.96 1,224.55

Shareholding Pattern

  • Promoter Group

    74.99%

  • Public Share Holding

    25.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 15,934,048 74.99 15,934,048 3
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 15,934,048 74.99 15,934,048 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 4,611 0.02 4,561 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 80,670 0.38 80,670 40
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 240,352 1.13 240,352 15
Mutual Funds / UTI 1,581,746 7.44 1,581,696 34
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 39,373 0.19 39,373 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,946,752 9.16 1,946,652 105
2] Non Institution
Bodies Corporate 149,839 0.71 149,749 734
Clearing Members 187 0.00 187 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 172,052 0.81 170,587 2,039
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 77,690 0.37 77,690 1,827
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 21,242 0.10 21,242 1
Individuals holding nominal share capital up to Rs. 1 lakh 2,829,177 13.31 2,698,270 73,598
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 890 0.00 890 6
Others 117,425 0.55 117,425 2
Sub Total 3,368,502 15.85 3,236,040 78,212
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,249,302 100.00 21,116,740 78,320

Company Background

Abbott India LtdPharmaceuticals - Multinational

  • Abbott India Ltd
  • BSE Code : 90.0
  • ISIN : INE358A01014

  • Incorporation Year

    1944

  • Registered Office

    Unit No 3 Corporate Park
    Sion Trombay Road Chembur, Mumbai,
    Maharashtra-400071

  • Telephone

    91-22-67978888/50461000/2000/1119

  • FAX

    91-22-50169400

  • Chairman

    Munir Shaikh

  • Managing Director

  • Company Secretary

    Sangeeta Shetty

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Abbott India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 28,146.90 7,217.19 6,929.05 38.54 43.78
Astrazeneca Phar 7,905.70 2,304.07 2,275.58 116.52 27.86
P & G Health Ltd 5,953.30 944.52 934.17 27.69 71.75
Glaxosmi. Pharma 2,619.65 3,932.76 3,790.20 41.85 58.17
Novartis India 1,594.65 398.23 356.27 40.27 16.64
Cipla 1,461.55 20,102.60 18,979.95 38.41 13.88
Bliss GVS Pharma 488.20 773.53 729.81 53.53 12.51
Amrutanjan Healt 487.20 469.50 451.82 24.32 21.89
Fermenta Biotec. 473.40 474.15 450.25 21.68 18.77
Guj. Themis Bio. 352.85 152.47 150.80 78.94 27.21
Ambalal Sarabhai 44.93 19.52 3.94 31.42 6.77